Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significance and the potential role of …

Y Chen, J Cortes, Z Estrov, S Faderl, W Qiao… - Journal of clinical …, 2011 - ascopubs.org
Purpose To determine the prognostic impact of persistent cytogenetic abnormalities at
complete remission (CR) on relapse-free survival (RFS) and overall survival (OS) in patients …

[引用][C] Persistence of Cytogenetic Abnormalities at Complete Remission After Induction in Patients With Acute Myeloid Leukemia: Prognostic Significance and the …

Y CHEN, J CORTES, T KADIA… - Journal of clinical …, 2011 - pascal-francis.inist.fr
Persistence of Cytogenetic Abnormalities at Complete Remission After Induction in Patients
With Acute Myeloid Leukemia: Prognostic Significance and the Potential Role of Allogeneic …

Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: Prognostic significance and the potential role of …

Y Chen, J Cortes, Z Estrov, S Faderl… - Journal of Clinical …, 2011 - ohiostate.elsevierpure.com
Purpose: To determine the prognostic impact of persistent cytogenetic abnormalities at
complete remission (CR) on relapse-free survival (RFS) and overall survival (OS) in patients …

Persistence of Cytogenetic Abnormalities at Complete Remission After Induction in Patients With Acute Myeloid Leukemia: Prognostic Significance and the Potential …

Y Chen, J Cortes, Z Estrov, S Faderl, W Qiao… - Journal of Clinical …, 2011 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> To determine the prognostic impact
of persistent cytogenetic abnormalities at complete remission (CR) on relapse-free survival …

Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significance and the potential role of …

Y Chen, J Cortes, Z Estrov, S Faderl… - Journal of clinical …, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose To determine the prognostic impact of persistent cytogenetic abnormalities at
complete remission (CR) on relapse-free survival (RFS) and overall survival (OS) in patients …

Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: Prognostic significance and the potential role of …

Y Chen, J Cortes, Z Estrov, S Faderl… - Journal of Clinical …, 2011 - augusta.elsevierpure.com
Purpose: To determine the prognostic impact of persistent cytogenetic abnormalities at
complete remission (CR) on relapse-free survival (RFS) and overall survival (OS) in patients …

Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: Prognostic significance and the potential role of …

Y Chen, J Cortes, Z Estrov… - Journal of …, 2011 - mdanderson.elsevierpure.com
Purpose: To determine the prognostic impact of persistent cytogenetic abnormalities at
complete remission (CR) on relapse-free survival (RFS) and overall survival (OS) in patients …

[PDF][PDF] Persistence of Cytogenetic Abnormalities at Complete Remission After Induction in Patients With Acute Myeloid Leukemia: Prognostic Significance and the …

Y Chen, J Cortes, Z Estrov, S Faderl, W Qiao… - J Clin …, 2011 - researchgate.net
Purpose To determine the prognostic impact of persistent cytogenetic abnormalities at
complete remission (CR) on relapse-free survival (RFS) and overall survival (OS) in patients …

[HTML][HTML] Persistence of Cytogenetic Abnormalities at Complete Remission After Induction in Patients With Acute Myeloid Leukemia: Prognostic Significance and the …

Y Chen, J Cortes, Z Estrov, S Faderl… - Journal of Clinical …, 2011 - ncbi.nlm.nih.gov
Purpose To determine the prognostic impact of persistent cytogenetic abnormalities at
complete remission (CR) on relapse-free survival (RFS) and overall survival (OS) in patients …

Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significance and the potential role of …

Y Chen, J Cortes, Z Estrov, S Faderl… - Journal of Clinical …, 2011 - europepmc.org
Purpose To determine the prognostic impact of persistent cytogenetic abnormalities at
complete remission (CR) on relapse-free survival (RFS) and overall survival (OS) in patients …